180 related articles for article (PubMed ID: 17475624)
1. Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24.
Fukushima T; Tezuka T; Shimomura T; Nakano S; Kataoka H
J Biol Chem; 2007 Jun; 282(25):18634-18644. PubMed ID: 17475624
[TBL] [Abstract][Full Text] [Related]
2. Roles of insulin-like growth factor binding protein-2 (IGFBP-2) in glioblastoma.
Fukushima T; Kataoka H
Anticancer Res; 2007; 27(6A):3685-92. PubMed ID: 17970029
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor binding protein-2 regulates β-catenin signaling pathway in glioma cells and contributes to poor patient prognosis.
Patil SS; Gokulnath P; Bashir M; Shwetha SD; Jaiswal J; Shastry AH; Arimappamagan A; Santosh V; Kondaiah P
Neuro Oncol; 2016 Nov; 18(11):1487-1497. PubMed ID: 27044294
[TBL] [Abstract][Full Text] [Related]
4. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
[TBL] [Abstract][Full Text] [Related]
5. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
6. Investigation of serum levels and tissue expression of two genes IGFBP-2 and IGFBP-3 act as potential biomarker for predicting the progression and survival in patients with glioblastoma multiforme.
Abdolhoseinpour H; Mehrabi F; Shahraki K; Khoshnood RJ; Masoumi B; Yahaghi E; Goudarzi PK
J Neurol Sci; 2016 Jul; 366():202-206. PubMed ID: 27288807
[TBL] [Abstract][Full Text] [Related]
7. IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion.
Song SW; Fuller GN; Khan A; Kong S; Shen W; Taylor E; Ramdas L; Lang FF; Zhang W
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):13970-5. PubMed ID: 14617774
[TBL] [Abstract][Full Text] [Related]
8. The microRNA-302b-inhibited insulin-like growth factor-binding protein 2 signaling pathway induces glioma cell apoptosis by targeting nuclear factor IA.
Lee CC; Chen PH; Ho KH; Shih CM; Cheng CH; Lin CW; Cheng KT; Liu AJ; Chen KC
PLoS One; 2017; 12(3):e0173890. PubMed ID: 28323865
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes.
Wang H; Wang H; Shen W; Huang H; Hu L; Ramdas L; Zhou YH; Liao WS; Fuller GN; Zhang W
Cancer Res; 2003 Aug; 63(15):4315-21. PubMed ID: 12907597
[TBL] [Abstract][Full Text] [Related]
10. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
[TBL] [Abstract][Full Text] [Related]
11. Deregulation of IGF-binding proteins -2 and -5 contributes to the development of endocrine resistant breast cancer in vitro.
Hawsawi Y; Humphries MP; Wright A; Berwick A; Shires M; Al-Kharobi H; El-Gendy R; Jove M; Twelves C; Speirs V; Beattie J
Oncotarget; 2016 May; 7(22):32129-43. PubMed ID: 27050076
[TBL] [Abstract][Full Text] [Related]
12. Role of glycosyltransferase PomGnT1 in glioblastoma progression.
Lan J; Guo P; Lin Y; Mao Q; Guo L; Ge J; Li X; Jiang J; Lin X; Qiu Y
Neuro Oncol; 2015 Feb; 17(2):211-22. PubMed ID: 25085363
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin (HAI-2/PB) in human glioblastomas: implication for anti-invasive role of HAI-2/PB in glioblastoma cells.
Hamasuna R; Kataoka H; Meng JY; Itoh H; Moriyama T; Wakisaka S; Koono M
Int J Cancer; 2001 Aug; 93(3):339-45. PubMed ID: 11433397
[TBL] [Abstract][Full Text] [Related]
14. Human cytomegalovirus US28 found in glioblastoma promotes an invasive and angiogenic phenotype.
Soroceanu L; Matlaf L; Bezrookove V; Harkins L; Martinez R; Greene M; Soteropoulos P; Cobbs CS
Cancer Res; 2011 Nov; 71(21):6643-53. PubMed ID: 21900396
[TBL] [Abstract][Full Text] [Related]
15. Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer.
Mehrian-Shai R; Chen CD; Shi T; Horvath S; Nelson SF; Reichardt JK; Sawyers CL
Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5563-8. PubMed ID: 17372210
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of β-arrestin 1 suppresses glioblastoma cell malignant progression vis inhibition of Src signaling.
Lan T; Wang H; Zhang Z; Zhang M; Qu Y; Zhao Z; Fan X; Zhan Q; Song Y; Yu C
Exp Cell Res; 2017 Aug; 357(1):51-58. PubMed ID: 28442265
[TBL] [Abstract][Full Text] [Related]
17. PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene.
Mayes DA; Hu Y; Teng Y; Siegel E; Wu X; Panda K; Tan F; Yung WK; Zhou YH
Cancer Res; 2006 Oct; 66(20):9809-17. PubMed ID: 17047041
[TBL] [Abstract][Full Text] [Related]
18. Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression.
Ben-Shmuel A; Shvab A; Gavert N; Brabletz T; Ben-Ze'ev A
Oncogene; 2013 Jul; 32(27):3220-30. PubMed ID: 22869145
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20.
Marucci G; Morandi L; Magrini E; Farnedi A; Franceschi E; Miglio R; Calò D; Pession A; Foschini MP; Eusebi V
Virchows Arch; 2008 Dec; 453(6):599-609. PubMed ID: 18953566
[TBL] [Abstract][Full Text] [Related]
20. IGFBP2 promotes immunosuppression associated with its mesenchymal induction and FcγRIIB phosphorylation in glioblastoma.
Liu Y; Song C; Shen F; Zhang J; Song SW
PLoS One; 2019; 14(9):e0222999. PubMed ID: 31560714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
